Prior therapy with anti-CD20 chimeric antibody (Rituximab) may decrease the risk of acute graft-versus-host disease (GVHD) in patients with non-Hodgkin's lymphoma receiving allogeneic stem cell transplantation.

被引：0
|
作者：
Ratanatharathorn, V
Bociek, RG
Pavletic, SZ
Lynch, JC
Ferrara, JLM
Uberti, JP
机构：
[1] Univ Michigan, Ctr Med, Ann Arbor, MI 48109 USA
[2] Univ Nebraska, Omaha, NE USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1688
引用
收藏
页码：391A / 391A
页数：1
相关论文
共 50 条
  • [21] Prior therapy with rituximab correlates with less acute graft-versus-host disease and better survival in B-Cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation (PBSCT)
    Ratanatharathorn, Voravit
    Horowitz, Mary M.
    Logan, Brian
    Arora, Mukta
    Wang, Dan
    Uberti, Joseph P.
    Gale, Robert P.
    Antin, Joseph H.
    Bornhaeuser, Martin
    Hale, Gregory A.
    Ringden, Olle
    Cairo, Mitchell S.
    Gupta, Vikas
    Cutler, Corey
    Anasetti, Claudio
    Pavletic, Steven Z.
    BLOOD, 2007, 110 (11) : 322A - 322A
  • [22] Conjunctival Acute Graft-versus-Host Disease in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study
    Liu, Yao-Chung
    Gau, Jyh-Pyng
    Lin, Pei-Yu
    Liu, Catherine Jui-Ling
    Liu, Chia-Jen
    Liu, Jin-Hwang
    Fan, Nai-Wen
    PLOS ONE, 2016, 11 (11):
  • [23] Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin’s lymphoma: results of a prospective randomized controlled trial
    Mathias Witzens-Harig
    Monika Reiz
    Christiane Heiß
    Axel Benner
    Manfred Hensel
    Kai Neben
    Peter Dreger
    Alwin Kraemer
    Anthony D. Ho
    Annals of Hematology, 2009, 88
  • [24] Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial
    Witzens-Harig, Mathias
    Reiz, Monika
    Heiss, Christiane
    Benner, Axel
    Hensel, Manfred
    Neben, Kai
    Dreger, Peter
    Kraemer, Alwin
    Ho, Anthony D.
    ANNALS OF HEMATOLOGY, 2009, 88 (01) : 51 - 57
  • [25] Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation
    Ratanatharathorn, Voravit
    Logan, Brent
    Wang, Dan
    Horowitz, Mary
    Uberti, Joseph P.
    Ringden, Olle
    Gale, Robert Peter
    Khoury, Hanna
    Arora, Mukta
    Spellman, Stephen
    Cutler, Corey
    Antin, Joseph
    Bornhaeuser, Martin
    Hale, Gregory
    Verdonck, Leo
    Cairo, Mitchell
    Gupta, Vikas
    Pavletic, Steven
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (06) : 816 - 824
  • [26] Elevation of activated platelet-dependent chemokines in patients with anti-CD20 monoclonal antibody (Rituximab)-treated non-Hodgkin's lymphoma
    Nomura, Shosaku
    Ishii, Kazuyoshi
    Kamitsuji, Yuka
    Uoshima, Nobuhiko
    Ishikawa, Emiko
    Kitayama, Hitoshi
    Hayashi, Kunio
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2007, 13 (02) : 206 - 212
  • [27] Acute graft versus host disease (GVHD) is increased in patients receiving cyclosporine/celicept as frontline prophylaxis against GVKD in pediatric patients undergoing allogeneic stem cell transplantation.
    Lakshminarayanan, Sonali
    Szabolcs, Paul
    Prasad, Vinod
    Parikh, Suhag
    Wood, Susan
    Ciocci, Gilbert
    Stafford, Lauren
    Boyd, Lynn
    Driscoll, Timothy
    Martin, Paul L.
    Kurtzberg, Joanne
    BLOOD, 2006, 108 (11) : 820A - 820A
  • [28] Anti-CD20 monoclonal antibody (rituximab) for therapy of T-cell/histiocyte-rich large B-cell non-Hodgkin lymphoma
    Park, ES
    Lim, JJ
    Kang, HJ
    Shin, HY
    Ahn, HS
    BLOOD, 2005, 106 (11) : 282B - 282B
  • [29] Petreatment with rituximab reduces the incidence of chronic graft-versus-host disease after allogeneic stem cell transplantation in patients with B cell lymphoma.
    Bornhaeuser, M
    Schwerdtfeger, R
    Kroschinsky, F
    Hanel, M
    Treptow, U
    Theuser, C
    Ehninger, G
    BLOOD, 2004, 104 (11) : 348A - 348A
  • [30] Rituximab maintenance therapy after autologous stem cell transplantation in patients with CD20+B-cell non-Hodgkin lymphoma - Feasibility
    Neumann, F
    Harmsen, S
    Martin, S
    Kronenwett, R
    Kondakci, M
    Fenk, R
    Haas, R
    Kobbe, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S8 - S8
12345